BR112015007243B1 - Processo aperfeiçoado para fabricação de 5-(2,6-di-4-morfolinil-4-pirimidinil)-4- trifluorometilpiridin-2-amina - Google Patents

Processo aperfeiçoado para fabricação de 5-(2,6-di-4-morfolinil-4-pirimidinil)-4- trifluorometilpiridin-2-amina Download PDF

Info

Publication number
BR112015007243B1
BR112015007243B1 BR112015007243-7A BR112015007243A BR112015007243B1 BR 112015007243 B1 BR112015007243 B1 BR 112015007243B1 BR 112015007243 A BR112015007243 A BR 112015007243A BR 112015007243 B1 BR112015007243 B1 BR 112015007243B1
Authority
BR
Brazil
Prior art keywords
trifluoromethyl
pyridin
acetamide
amine
solvents
Prior art date
Application number
BR112015007243-7A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112015007243A2 (pt
Inventor
Murat Acemoglu
Dietmar Flubacher
Nicole Bieri
Pascal Michel
Rasmus Mose
Hans Stettler
Maria Caterina Testa
Jorg Brozio
Frank Schaefer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR112015007243A2 publication Critical patent/BR112015007243A2/pt
Publication of BR112015007243B1 publication Critical patent/BR112015007243B1/pt

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
BR112015007243-7A 2012-10-23 2013-10-21 Processo aperfeiçoado para fabricação de 5-(2,6-di-4-morfolinil-4-pirimidinil)-4- trifluorometilpiridin-2-amina BR112015007243B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261717237P 2012-10-23 2012-10-23
US61/717,237 2012-10-23
US201361842101P 2013-07-02 2013-07-02
US61/842,101 2013-07-02
PCT/EP2013/071996 WO2014064058A1 (en) 2012-10-23 2013-10-21 Improved process for manufacturing 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine

Publications (2)

Publication Number Publication Date
BR112015007243A2 BR112015007243A2 (pt) 2017-07-04
BR112015007243B1 true BR112015007243B1 (pt) 2022-02-08

Family

ID=49448162

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015007243-7A BR112015007243B1 (pt) 2012-10-23 2013-10-21 Processo aperfeiçoado para fabricação de 5-(2,6-di-4-morfolinil-4-pirimidinil)-4- trifluorometilpiridin-2-amina

Country Status (15)

Country Link
US (1) US9637468B2 (enExample)
EP (1) EP2912030B1 (enExample)
JP (1) JP6267213B2 (enExample)
KR (1) KR102128127B1 (enExample)
CN (1) CN104736532B (enExample)
AU (2) AU2013336807B2 (enExample)
BR (1) BR112015007243B1 (enExample)
CA (1) CA2885471C (enExample)
ES (1) ES2605638T3 (enExample)
IN (1) IN2015DN01331A (enExample)
MX (1) MX360703B (enExample)
PL (1) PL2912030T3 (enExample)
PT (1) PT2912030T (enExample)
RU (1) RU2646760C2 (enExample)
WO (1) WO2014064058A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140069235A (ko) 2011-09-27 2014-06-09 노파르티스 아게 돌연변이체 idh의 억제제로서의 3-피리미딘-4-일-옥사졸리딘-2-온
UY34632A (es) 2012-02-24 2013-05-31 Novartis Ag Compuestos de oxazolidin- 2- ona y usos de los mismos
US9296733B2 (en) 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
CN105050602B (zh) * 2013-01-12 2018-05-25 张大为 作为pi3激酶抑制剂的吡啶化合物
KR20150131224A (ko) 2013-03-14 2015-11-24 노파르티스 아게 돌연변이 idh의 억제제로서의 3-피리미딘-4-일-옥사졸리딘-2-온
CA2944697C (en) 2014-04-22 2022-07-19 Universitaet Basel Manufacturing process for triazine, pyrimidine and pyridine derivatives
WO2016050201A1 (zh) * 2014-09-29 2016-04-07 山东轩竹医药科技有限公司 高选择性取代嘧啶类pi3k抑制剂
CN105085476B (zh) * 2014-11-24 2018-03-09 苏州晶云药物科技有限公司 5‑[2,6‑二(4‑吗啉基)‑4‑嘧啶基]‑4‑(三氟甲基)‑2‑吡啶胺二盐酸盐的晶型及其制备方法
CN105001151B (zh) * 2015-08-28 2017-07-14 苏州明锐医药科技有限公司 布帕尼西中间体及其制备方法
CN106543140A (zh) * 2015-09-21 2017-03-29 苏州晶云药物科技有限公司 5-[2,6-二(4-吗啉基)-4-嘧啶基]-4-(三氟甲基)-2-吡啶胺盐酸盐的晶型及其制备方法
CN107793394A (zh) * 2017-08-03 2018-03-13 上海厚璞生物科技有限公司 一种生产选择性pi3k抑制剂的系列关键中间体
IL283901B2 (en) * 2018-12-18 2025-03-01 Astrazeneca Ab Process and intermediates for the preparation of 4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-((R)-S-methylsulfonimidoyl)cyclopropyl]pyrimidin-2-yl}-1H-pyrrolo[2,3-b]pyridine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062805A1 (en) * 2001-02-08 2002-08-15 Toyama Chemical Co., Ltd. 6-substituted alkylamino-3-pyridylboric acid derivative or salt thereof and processes for producing these
JP4673218B2 (ja) * 2002-11-21 2011-04-20 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド ホスホチジルイノシトール（ｐｉ）３−キナーゼインヒビターとしての２，４，６−三置換ピリミジン、および癌の処置におけるその使用
JO2660B1 (en) * 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
EP2621908A2 (en) * 2010-10-01 2013-08-07 Novartis AG Manufacturing process for pyrimidine derivatives

Also Published As

Publication number Publication date
CA2885471A1 (en) 2014-05-01
RU2015119259A (ru) 2016-12-20
CA2885471C (en) 2021-02-23
CN104736532A (zh) 2015-06-24
MX360703B (es) 2018-11-14
US20150246897A1 (en) 2015-09-03
CN104736532B (zh) 2017-04-05
EP2912030B1 (en) 2016-08-31
KR102128127B1 (ko) 2020-06-30
IN2015DN01331A (enExample) 2015-07-03
JP2016502510A (ja) 2016-01-28
AU2016238941A1 (en) 2016-11-03
ES2605638T3 (es) 2017-03-15
EP2912030A1 (en) 2015-09-02
MX2015005188A (es) 2015-09-07
WO2014064058A1 (en) 2014-05-01
BR112015007243A2 (pt) 2017-07-04
AU2013336807A1 (en) 2015-03-05
PT2912030T (pt) 2016-11-30
AU2013336807B2 (en) 2016-10-27
PL2912030T3 (pl) 2017-02-28
KR20150072408A (ko) 2015-06-29
US9637468B2 (en) 2017-05-02
JP6267213B2 (ja) 2018-01-24
RU2646760C2 (ru) 2018-03-07

Similar Documents

Publication Publication Date Title
BR112015007243B1 (pt) Processo aperfeiçoado para fabricação de 5-(2,6-di-4-morfolinil-4-pirimidinil)-4- trifluorometilpiridin-2-amina
JP6439050B2 (ja) Ａｓｋ１阻害剤を調製するプロセス
JP5117493B2 (ja) ヒンバシン類似体の合成において使用される｛［５−（３−フルオロフェニル）−ピリジン−２−イル］メチル｝ホスホン酸ジエチルの合成
JP6997172B2 (ja) オラパリブの製造方法
CN107663190B (zh) 一种尼拉帕尼及其中间体的制备方法以及中间体化合物
CN111943930B (zh) Lasmiditan的合成工艺
JP2004520446A (ja) ロサルタンカリウムの結晶化方法
CN111646936A (zh) 芳香醚类化合物的制备方法
CN111004235A (zh) 一种ATX抑制剂Ziritaxestat的合成方法
CN111349045A (zh) 乐伐替尼的合成方法及新的中间体
US9290439B2 (en) Process for preparing cinacalcet and pharmaceutically acceptable salts thereof
CA3029361A1 (en) New processes for the preparation of vemurafenib
CN108948080A (zh) 一种福沙匹坦药用盐的制备方法
US7714127B2 (en) Process for making heteroaryl amine intermediate compounds
TWI685485B (zh) 阿卡替尼（acalabrutinib）之製造方法
CN115215788B (zh) 一种色瑞替尼关键中间体的制备方法
CN102617500B (zh) 一种利奈唑胺中间体、其制备方法和利奈唑胺的制备方法
EP1539751A4 (en) PROCESS FOR PREPARING IMIDAZO (1,2-A) PYRIDINE-3-ACETAMIDES
JP2011526257A (ja) Ｎ−フェニル−ｎ−（４−ピペリジニル）アミド塩の製造方法
CN108473510B (zh) 制备2-吡唑并[1,5-a]吡嗪-2-基吡啶并[1,2-a]嘧啶-4-酮的方法
WO2015163446A1 (ja) イミダゾール化合物の製造方法
CN114835650A (zh) 噁拉戈利中间体的盐、晶体及其制备方法和应用
WO2006137335A1 (ja) ピペラジン誘導体の製造方法
CA3214107A1 (en) New process for the synthesis of 5-{5-chloro-2-[(3s)-3- [(morpholin-4-yl)methyl]-3,4-dihydroisoquinoline-2(1h)- carbonyl]phenyl}-1,2-dimethyl-1h-pyrrole-3-carboxylic acid derivatives and its application for the production of pharmaceutical compounds
CN114835649A (zh) 噁拉戈利盐、晶体及其制备方法和应用

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07D 401/14 , C07D 401/04 , C07D 239/28 , C07D 239/42

Ipc: C07D 401/14 (2006.01), C07D 401/04 (2006.01), ...

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/10/2013, OBSERVADAS AS CONDICOES LEGAIS.